These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 19578386)
1. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386 [TBL] [Abstract][Full Text] [Related]
2. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808 [TBL] [Abstract][Full Text] [Related]
3. Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells. Prajapati V; Kale RK; Singh RP Nutr Cancer; 2015; 67(4):647-58. PubMed ID: 25868784 [TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling. Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031 [TBL] [Abstract][Full Text] [Related]
5. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway. Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629 [TBL] [Abstract][Full Text] [Related]
6. Silibinin Inhibits Cell Invasion through the Inhibition of MMPs, Jo AI; Kim MM Front Biosci (Landmark Ed); 2023 Apr; 28(4):64. PubMed ID: 37114542 [TBL] [Abstract][Full Text] [Related]
7. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway. Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212 [TBL] [Abstract][Full Text] [Related]
8. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508 [TBL] [Abstract][Full Text] [Related]
9. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Chu SC; Chiou HL; Chen PN; Yang SF; Hsieh YS Mol Carcinog; 2004 Jul; 40(3):143-9. PubMed ID: 15224346 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response. Yousefi M; Ghaffari SH; Soltani BM; Nafissi S; Momeny M; Zekri A; Behmanesh M; Alimoghaddam K; Ghavamzadeh A Neurochem Res; 2012 Sep; 37(9):2053-63. PubMed ID: 22717697 [TBL] [Abstract][Full Text] [Related]
11. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Hwang ES; Park KK Biosci Biotechnol Biochem; 2010; 74(5):961-7. PubMed ID: 20460721 [TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Singh RP; Raina K; Sharma G; Agarwal R Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104 [TBL] [Abstract][Full Text] [Related]
13. Impact of hypoxia on the metastatic potential of human prostate cancer cells. Dai Y; Bae K; Siemann DW Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):521-8. PubMed ID: 21640519 [TBL] [Abstract][Full Text] [Related]
14. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway. Momeny M; Ghasemi R; Valenti G; Miranda M; Zekri A; Zarrinrad G; Javadikooshesh S; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH Tumour Biol; 2016 Mar; 37(3):3913-23. PubMed ID: 26482609 [TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro. Lin CM; Chen YH; Ma HP; Wang BW; Chiu JH; Chua SK; Ong JR; Shyu KG J Agric Food Chem; 2012 Dec; 60(51):12451-7. PubMed ID: 23210512 [TBL] [Abstract][Full Text] [Related]
16. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells. Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514 [TBL] [Abstract][Full Text] [Related]
17. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway. Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024 [TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression. Kim S; Han J; Jeon M; You D; Lee J; Kim HJ; Bae S; Nam SJ; Lee JE Tumour Biol; 2016 Aug; 37(8):11397-407. PubMed ID: 26984157 [TBL] [Abstract][Full Text] [Related]
20. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity. Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]